While the results may seem contradictory, it was interesting to note that the reported downregulation of claudin-18.2 expression occurred more frequently in the intestinal variant than in the diffuse variant of gastric cancers (significant expression in 46% versus 75%) [32]. Here, CLDN18 is linked to gastric cancer.